Athersys Competitors and Similar CompaniesClear all

Athersys's competitors and similar companies include Seed Health, BeyondSpring and Ipsen.

	Athersys Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.	Seed Health Seed Health is a microbial sciences company developing applications of bacteria to impact human and environmental health.	BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.	Ipsen Ipsen is a biopharmaceutical company.
Founding Date	Founding Date 1995	Founding Date 2016	Founding Date 2010	Founding Date 1929
Type	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development supplements	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Cleveland, US HQ Canton, US	Locations Venice, US HQ	Locations Florham Park, US HQ	Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more
Employees	Employees 8311% increase	Employees 234	Employees 4014% increase	Employees 5,358
Valuation ($)	Valuation ($) 6.3 m	Valuation ($) N/A	Valuation ($) 89.4 m	Valuation ($) 10.2 b
Financial
Revenue (est.)	Revenue (est.) $5.3m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €3.7b (FY, 2025)
Net income	Net income ($72.5m) (FY, 2022)	Net income N/A	Net income ($16.7m) (FY, 2024)	Net income €445.1m (FY, 2025)
Operating ⚠
Patents (US)	Patents (US) 21 (FY, 2016)	Patents (US) N/A	Patents (US) 20 (Mar, 2020)	Patents (US) N/A
Funding
Total funding raised	Total funding raised $ 9m	Total funding raised $ 40m	Total funding raised $ 36.1m	Total funding raised N/A